Dr Rahul Bhargava

Autologous Stem Cell Transplant Treatment in India

Book a Consultation Call

An autologous stem cell transplant (ASCT) is a medical procedure in which stem cells are harvested from a patient's own body, stored, and then re-infused after intensive chemotherapy or radiation therapy. This type of transplant is used primarily to treat blood cancers such as lymphoma, multiple myeloma, and certain types of leukemia, as well as non-cancerous conditions like autoimmune diseases (e.g., multiple sclerosis).

Unlike an allogeneic stem cell transplant, where the stem cells come from a donor, autologous SCT uses the patient’s own cells, which reduces the risk of graft-versus-host disease (GVHD). However, it also limits the potential benefits of a donor immune system helping fight the disease, as seen in allogeneic transplants.

Book a Consultation Call

What is an Autologous Stem Cell Transplant?

Autologous stem cell transplant is a procedure where a patient’s own healthy stem cells are harvested and reintroduced after high-dose chemotherapy or radiation. This type of transplant is typically used to treat various blood-related diseases and cancers, such as:

  • Multiple Myeloma
  • Lymphomas (Non-Hodgkin’s and Hodgkin’s)
  • Certain types of leukemia
  • Other bone marrow disorders

By using the patient’s own cells, the risk of rejection is minimized, offering a safer and effective treatment option.

Causes of Conditions Treated by Autologous Stem Cell Transplant

  1. Genetic Mutations: Certain genetic mutations can lead to abnormal cell growth, causing cancers like leukemia, lymphoma, and multiple myeloma.
  2. Environmental Factors: Exposure to chemicals, radiation, and certain viruses may increase the risk of developing blood cancers.
  3. Immune System Dysfunction: Autoimmune diseases occur when the immune system mistakenly attacks healthy cells and tissues. This dysfunction is often linked to genetic factors, infections, or environmental triggers.
  4. Chemotherapy-Induced Damage: Some cancer treatments can damage bone marrow, requiring stem cell transplants to restore healthy cells.

Types of Conditions Treated by Autologous Stem Cell Transplant

  1. Blood Cancers

    • Lymphoma: Includes Hodgkin’s and Non-Hodgkin’s Lymphoma, where abnormal lymphocytes grow uncontrollably.
    • Leukemia: Specifically Acute Myeloid Leukemia (AML) and Chronic Myeloid Leukemia (CML), which affect white blood cell production.
    • Multiple Myeloma: A cancer that affects plasma cells in the bone marrow, leading to weakened bones and immune function.
  2. Autoimmune Disorders

    • Lupus: An autoimmune disease that affects various parts of the body, leading to inflammation and organ damage.
    • Systemic Sclerosis (Scleroderma): A condition characterized by hardening and tightening of the skin and connective tissues.

Symptoms That Might Lead to Stem Cell Transplant Consideration

Patients who may benefit from an autologous stem cell transplant may exhibit symptoms depending on the underlying condition, such as:

  • Persistent fatigue
  • Frequent infections
  • Unexplained weight loss
  • Anemia
  • Bone pain (common in multiple myeloma)
  • Swollen lymph nodes
  • Fever and night sweats (common in lymphomas)

If these symptoms persist and traditional treatments fail, a stem cell transplant may be recommended.

How is an Autologous Stem Cell Transplant Diagnosed?

Before undergoing an autologous stem cell transplant, patients must undergo extensive testing and diagnostic procedures, including:

  1. Blood Tests: To assess the patient’s overall health, kidney, liver, and blood cell counts.
  2. Bone Marrow Biopsy: This helps diagnose the stage of the disease and the health of the bone marrow.
  3. Imaging Tests: Such as CT scans or PET scans to locate any signs of cancer or disease.
  4. Stem Cell Collection Tests: To ensure that enough healthy stem cells can be harvested for the transplant.

Treatment Process for Autologous Stem Cell Transplant

  1. Pre-Transplant Treatment: Before the transplant, high-dose chemotherapy or radiation therapy is used to eliminate cancerous or diseased cells in the body. While this eradicates the cancer, it also destroys the bone marrow, which is why the reintroduction of stem cells is essential.
  2. Stem Cell Harvesting: Stem cells are harvested from the patient’s blood using a process called apheresis. This is usually done over several days.
  3. Stem Cell Infusion: After the high-dose chemotherapy, the harvested stem cells are infused back into the patient’s bloodstream, where they begin the process of regenerating healthy bone marrow.
  4. Recovery: Recovery after an autologous stem cell transplant typically involves a hospital stay of several weeks as the immune system rebuilds. During this time, patients are closely monitored for complications like infections.

Cost of Treatment and Stay in India

The cost of undergoing an autologous stem cell transplant in India is considerably lower compared to many Western countries, making it an attractive option for international patients. The total cost of treatment depends on the type of disease, complexity of the case, and the duration of the treatment and recovery. Here’s an overview of the costs:

  • Initial Consultation:
    USD: $30 – $100
    INR: ₹2,200 – ₹7,400

  • Stem Cell Collection and Processing:
    USD: $2,000 – $5,000
    INR: ₹1,50,000 – ₹3,70,000

  • Chemotherapy or Radiation Therapy (pre-transplant):
    USD: $500 – $2,500
    INR: ₹37,000 – ₹1,85,000

  • Autologous Stem Cell Transplant (including all procedures):
    USD: $12,000 – $30,000
    INR: ₹10,00,000 – ₹24,00,000

  • Hospital Stay (per night):
    USD: $25 – $200
    INR: ₹2,000 – ₹15,000

India offers affordable healthcare services, making it a popular destination for autologous stem cell transplants. The cost of treatment is much lower than in Western countries, with high-quality care provided by experienced specialists, ensuring successful outcomes and personalized treatment.

Frequently Asked Questions

autologous transplants have fewer complications than allogeneic transplants, patients may still experience infections, graft failure, or organ damage due to chemotherapy. However, these risks are managed with close monitoring and care.

The success rates vary depending on the disease being treated. For example, for multiple myeloma, the 5-year survival rate after autologous transplant can range from 50% to 80%, depending on the patient’s overall health and other factors

No, in an autologous stem cell transplant, only the patient’s own stem cells are used. For some conditions, an allogeneic transplant (using donor cells) may be more suitable.

Recovery involves rebuilding the immune system, which can take a few months. During this time, patients need to follow strict hygiene measures to avoid infections and may need blood transfusions and other supportive treatments.
Send a query